Snowball logo
logo
HMGN

Hemagen Diagnostics Inc

HMGN • PINK
$0.0002$0.00  (0%)
Estimate
Beta
1,053.343
About the company
Ticker
HMGN
ISIN
US4235011057
Country
United States of America
Sector (GICS)
Healthcare
Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

Frequently asked questions

What sector does Hemagen Diagnostics Inc (HMGN) operate in?

Hemagen Diagnostics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Hemagen Diagnostics Inc (HMGN) current stock price?

As of the latest data, Hemagen Diagnostics Inc stock price is $0.00, with a previous close of $0.00.

What is Hemagen Diagnostics Inc (HMGN) current market capitalization?

Hemagen Diagnostics Inc market cap is approximately 3.10 thousand.

Does Hemagen Diagnostics Inc (HMGN) pay dividends?

No. Hemagen Diagnostics Inc does not pay a dividend.

What is Hemagen Diagnostics Inc (HMGN) beta (volatility) score?

Hemagen Diagnostics Inc has a beta of 1053.343, indicating very high volatility compared to the market.